Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: Differences between human and rat

被引:160
作者
Natsume, M
Osakabe, N
Oyama, M
Sasaki, M
Baba, S
Nakamura, Y
Osawa, T
Terao, J
机构
[1] Meiji Seika Kaisha Ltd, Hlth & Biosci Labs, Sakado, Saitama 3500289, Japan
[2] Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Kanagawa, Japan
[3] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan
[4] Univ Tokushima, Sch Med, Dept Nutr, Tokushima 770, Japan
关键词
-(-)-epicatechin; metabolites; glucuronidation; rat; human; free radicals;
D O I
10.1016/S0891-5849(02)01434-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(-)-Epicatechin is one of the most potent antioxidants present in the human diet. Particularly high levels are found in black tea, apples, and chocolate. High intake of catechins has been associated with reduced risk of cardiovascular diseases. There have been several reports concerning the bioavailability of catechins, however, the chemical structure of (-)-epicatechin metabolites in blood, tissues, and urine remains unclear. In the present study, we purified and elucidated the chemical structure of (-)-epicatechin metabolites in human and rat urine after oral administration. Three metabolites were purified from human urine including (-)-epicatechin-3'-O-glucuronide, 4'-O-methyl-(-)-epicatechin-3'-O-glucuronide, and 4'-O-methyl-(-)-epicatechin-5 or 7-O-glucuronide, according to H-1- and C-13-NMR, HMBC, and LC-MS analyses. The metabolites purified from rat urine were 3'-O-methyl-(-)-epicatechin, (-)-epicatechin-7-O-glucuronide, and 3'-O-methyl-(-)-epicatechin-7-O-glucuronide. These compounds were also detected in the blood of humans and rats by LC-MS. The presence of these metabolites in blood and urine suggests that catechins are metabolized and circulated in the body after administration of catechin-containing foods. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:840 / 849
页数:10
相关论文
共 17 条
  • [1] Dietary catechins in relation to coronary heart disease death among postmenopausal women
    Arts, ICW
    Jacobs, DR
    Harnack, LJ
    Gross, M
    Folsom, AR
    [J]. EPIDEMIOLOGY, 2001, 12 (06) : 668 - 675
  • [2] Arts ICW, 2001, AM J CLIN NUTR, V74, P227
  • [3] Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers
    Baba, S
    Osakabe, N
    Yasuda, A
    Natsume, M
    Takizawa, T
    Nakamura, T
    Terao, J
    [J]. FREE RADICAL RESEARCH, 2000, 33 (05) : 635 - 641
  • [4] Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats
    Baba, S
    Osakabe, N
    Natsume, M
    Muto, Y
    Takizawa, T
    Terao, J
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (12) : 6050 - 6056
  • [5] Baba S, 2000, BRIT J NUTR, V84, P673
  • [6] Regioselectivity of phase 11 metabolism of luteolin and quercetin by UDP-glucuronosyl transferases
    Boersma, MG
    van der Woude, H
    Bogaards, J
    Boeren, S
    Vervoort, J
    Cnubben, NHP
    van Iersel, MLPS
    van Bladeren, PJ
    Rietjens, IMCM
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (05) : 662 - 670
  • [7] Induction of UDP-glucuronosyl-transferase by the flavonoids chrysin and quercetin in Caco-2 cells
    Galijatovic, A
    Walle, UK
    Walle, T
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (01) : 21 - 26
  • [8] Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin
    Harada, M
    Kan, Y
    Naoki, H
    Fukui, Y
    Kageyama, N
    Nakai, M
    Miki, W
    Kiso, Y
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1999, 63 (06) : 973 - 977
  • [9] DIETARY ANTIOXIDANT FLAVONOIDS AND RISK OF CORONARY HEART-DISEASE - THE ZUTPHEN ELDERLY STUDY
    HERTOG, MGL
    FESKENS, EJM
    HOLLMAN, PCH
    KATAN, MB
    KROMHOUT, D
    [J]. LANCET, 1993, 342 (8878) : 1007 - 1011
  • [10] Flavonoid intake and coronary mortality in Finland: A cohort study
    Knekt, P
    Jarvinen, R
    Reunanen, A
    Maatela, J
    [J]. BRITISH MEDICAL JOURNAL, 1996, 312 (7029) : 478 - 481